EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, INO: Inovio Pharma

27 Oct 25 15:59
LAST:

2.480

CHANGE:
 0.16		OPEN:
2.370		HIGH:
2.670		ASK:
5.550		VOLUME:
2.03M
CHG(%):
6.87		PREV:
2.330		LOW:
2.370		BID:
7.850		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
27 Oct 252.5602.6602.4702.4902.17M
24 Oct 252.2802.3402.2702.330628.1K
23 Oct 252.2302.3102.2112.250495.8K
22 Oct 252.3002.3102.2202.2201.25M
21 Oct 252.4702.4902.3152.3301.63M
20 Oct 252.4002.4802.3802.470519.2K
17 Oct 252.4202.4452.3502.350709.5K
16 Oct 252.5802.6302.4102.460842.6K
15 Oct 252.4902.5802.4502.540731.5K
14 Oct 252.4102.4602.3662.440782.9K

COMPANY PROFILE

Name:Inovio Pharma
About:Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. Its products in pipeline include VGX-3100 for the treatment of HPV-related cervical high-grade dysplasia; INO-3107 for HPV-related recurrent respiratory papillomatosis and is under Phase 1/2 trial; INO-3112 for the treatment of HPV-related Oropharyngeal Squamous Cell Carcinoma and is under Phase 2 trial; INO-5401 for the treatment of glioblastoma multiforme and is under Phase 2 trial; INO-4201 for Ebola Virus Disease and is under Phase 1b trial; INO-4800 for COVID-19 and is under Phase 3 trial; and INO-6160 for the treatment of human immunodeficiency virus and is under Phase 1 trial. Its partners and collaborators include Advaccine Biopharmaceuticals Suzhou Co, ApolloBio Corporation, AstraZeneca, The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations, Defense Advanced Research Projects Agency, The U.S. Department of Defense, HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, the University of Pennsylvania, Plumbline Life Sciences, Regeneron Pharmaceuticals, Richter BioLogics, the Walter Reed Army Institute of Research, and The Wistar Institute. The company was incorporated in 1983 and is headquartered in Plymouth Meeting, Pennsylvania.
Sector:Healthcare
Industry:Biotechnology
Address:660 West Germantown Pike, Plymouth Meeting, PA, United States, 19462
Website:https://www.inovio.com
CUSIP:371916305
CIK:0001055726
ISIN:US45773H4092
FIGI:BBG000BK6YX5

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:2.326.7%
MA10:2.393.9%
MA20:2.432.2%
MA50:2.393.7%
MA100:2.0421.6%
MA200:1.9924.7%
STO9:61.36
STO14:58.70
RSI14:53.57
WPR14:-37.21
MTM14:-0.07
ROC14:-0.03 
ATR:0.17 
Week High:2.667.3%
Week Low:2.2112.2%
Month High:2.688.1%
Month Low:2.2124.7%
Year High:5.80133.9%
Year Low:1.3090.8%
Volatility:42.47 

RECENT SPLITS

Date Ratio
25 Jan 20241-12
06 Jun 20141-4
13 Sep 20041-4

RECENT DIVIDENDS

Date Amount
28 Sep 2017$0.07
29 Aug 2017$0.07